Lori Hu - Profile and Investment Details

Investor Profile

Lori Hu is a Venture Capital, Private Equity Firm, Investor based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as Indapta Therapeutics, Bicycle Therapeutics, Moximed, SonoThera, Kona Medical, NeuSpera Medical, Palleon Pharmaceuticals, Epirium Bio, Neuspera Medical Inc., Elevation Oncology, BlackThorn Therapeutics, Ivantis, Inc, Obsidian Therapeutics, Nuvaira, Visterra, Innoventure, TORL BioTherapeutics, LLCTwentyeight-Seven Therapeutics, Twelve, Bristol-Myers Squibb, SENSIMED, Earlens Corporation, Ivantis, . Over time, Lori Hu has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Lori Hu is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Women Founded, Investment Management, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Information Technology (IT), Venture Fundraising, Biotechnology, Medical Devices, Clinical Trials, FinTech, Digital Health, Developer Tools, Medical, Information Technology, B2B, Therapeutics, Health Tech, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Lori Hu, as their portfolio suggests a familiarity and interest in this area.

Understanding Lori Hu’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.